TrialJAMA network open2024

Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.

Shuchi Gulati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.